AGIO
Agios Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$33.10
−0.09%Margins
Gross margin
87.9%
EBITDA margin
-423.8%
EBIT margin
-466.8%
Net margin
-418.2%
FCF margin
-371.4%
-40.1%
Return on equity
-37.1%
Return on assets
-43.4%
Return on invested capital
0.09x
Asset turnover
-$360.6M
Cash from operations
$10
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026